Clinical trialNCT07221188RecruitingPhase 3Interventional

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

SponsorGlaxoSmithKlineEnrollment1,250Non-alcoholic Fatty Liver Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Gsk Investigational Site
Arcadia, California, United States
Elias Tarakji
Recruiting
Gsk Investigational Site
Covina, California, United States
Masoud Azizad
Recruiting
Gsk Investigational Site
Los Angeles, California, United States
Joseph Lamb
Recruiting
Gsk Investigational Site
Santa Maria, California, United States
Keval Shah
Recruiting
Gsk Investigational Site
Cape Coral, Florida, United States
Paige Kreegel
Recruiting
Gsk Investigational Site
Doral, Florida, United States
Jorge Diaz
Recruiting
Gsk Investigational Site
Hialeah, Florida, United States
Isaac Bassan, MD
Recruiting
Gsk Investigational Site
Inverness, Florida, United States
Paul Hellstern Jr.
Recruiting
Gsk Investigational Site
Jacksonville, Florida, United States
Jeffry Jacqmein
Recruiting
Gsk Investigational Site
Kissimmee, Florida, United States
Luis Alvarado
Recruiting
Gsk Investigational Site
Lakeland, Florida, United States
James Andersen
Recruiting
Gsk Investigational Site
Maitland, Florida, United States
Eva Maria Heurich
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Lazaro M Garcia
Recruiting
Gsk Investigational Site
Miami, Florida, United States
JORGE AMAYA
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Franciso Bautista
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Yaneicy Gonzalez Rojas
Recruiting
Gsk Investigational Site
Miami Lakes, Florida, United States
Miguel Aponte
Recruiting
Gsk Investigational Site
Ocala, Florida, United States
Robert Barish
Recruiting
Gsk Investigational Site
Palmetto Bay, Florida, United States
Karen Figueredo Reyes
Recruiting
Gsk Investigational Site
Topeka, Kansas, United States
Shekhar Challa
Recruiting
Gsk Investigational Site
Springfield, Missouri, United States
Dmitry Shuster
Recruiting
Gsk Investigational Site
St Louis, Missouri, United States
Fred Williams
Recruiting
Gsk Investigational Site
Jersey City, New Jersey, United States
Samar Hameed
Recruiting
Gsk Investigational Site
East Syracuse, New York, United States
Barbara Connor
Recruiting
Gsk Investigational Site
New York, New York, United States
Eli Shalenberg
Recruiting
Gsk Investigational Site
Morehead City, North Carolina, United States
Kathryn Lucas
Recruiting
Gsk Investigational Site
Akron, Ohio, United States
Ganesh Veerappan
Recruiting
Gsk Investigational Site
Springboro, Ohio, United States
Anjali Morey
Recruiting
Gsk Investigational Site
Austin, Texas, United States
Nomita Kim
Recruiting
Gsk Investigational Site
Austin, Texas, United States
Michael Patrick Zimmerman
Recruiting
Gsk Investigational Site
Brownsville, Texas, United States
Christopher Romero
Recruiting
Gsk Investigational Site
Dallas, Texas, United States
Valentine Ebuh
Recruiting
Gsk Investigational Site
DeSoto, Texas, United States
Haresh Boghara
Recruiting
Gsk Investigational Site
Richmond, Texas, United States
Brian Chou
Recruiting
Gsk Investigational Site
San Antonio, Texas, United States
Eric Lawitz →
Recruiting
Gsk Investigational Site
San Antonio, Texas, United States
Emanuel DeNoia
Recruiting
Gsk Investigational Site
Seabrook, Texas, United States
Joe Pouzar
Recruiting
Gsk Investigational Site
Tomball, Texas, United States
Muhammad Irfan
Recruiting
Gsk Investigational Site
Waco, Texas, United States
Gregg Lucksinger
Recruiting
Gsk Investigational Site
Waco, Texas, United States
Hanumantha Ancha
Recruiting

3 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Dec 2025
Primary completion: 24 Mar 2028
Completion: 24 Mar 2028
Last update posted: 16 Apr 2026
Registered enrollment: 1,250
Registry id: NCT07221188

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-523674-16

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.